News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3127last 7d
512● bullish (7d)
311● bearish (7d)
227publishers
Simply Wall St.41d agobearish
Boston Scientific (BSX) Faces A Recall, Is The 28% Undervaluation Still Compelling?Simply Wall St.41d agobearish
What Do Boston Scientific (BSX) Recall And Executive Retirement Mean For Investors?Simply Wall St.53d agobearish
Boston Scientific (BSX) Recalls LUX Dx Cardiac Monitor Over Delayed AF AlertsInsider Monkey56d agobearish
Boston Scientific (BSX) Didn’t Miss on Demand or Devices. A Cyberattack Just Broke Its Guidance.MT Newswires61d agobearish
Boston Scientific Flags Guidance Miss Amid 'Material Impact' From Cybersecurity Incident; Shares FallBarrons.com61d agobearish
Boston Scientific ‘Unlikely to Meet’ Earnings Guidance After Cyberattack. Stock Falls.Simply Wall St.65d agobearish
Did Recalls And Cyberattack Disruptions Just Shift Boston Scientific's (BSX) Investment Narrative?Simply Wall St.66d agobearish
Boston Scientific (BSX) Could Be 23% Undervalued After Recalls And Cyber IncidentSimply Wall St.93d agobearish
What Do Boston Scientific (BSX) Recalls Mean For Device Safety And Clinical Use?Simply Wall St.101d agobearish
Boston Scientific (BSX) Is Up 7.1% After Q2 Beat, Recall And Major Restructuring Plan - Has The Bull Case Changed?Medical Device Network103d agobearish
Boston Scientific expects headcount reductions amid restructuring initiativeSimply Wall St.109d agobearish
Boston Scientific (BSX) Recalls Put Focus On Whether The Stock Still Looks UndervaluedSimply Wall St.117d agobearish
Are Boston Scientific’s (BSX) Sterile-Packaging Recalls Reframing the Narrative on Quality and Regulatory Risk?Simply Wall St.137d agobearish
How a Targeted Valve Recall and Watchman Questions at Boston Scientific (BSX) Have Changed Its Investment StorySimply Wall St.137d agobearish
Boston Scientific (BSX) Recalls Orca Valves Nationwide After Device MalfunctionInvesting.com163d agobearish
Wolfe Research cuts Boston Scientific rating as key growth drivers falter